N. Morlet et al., HIGH-DOSE INTRAVITREAL GANCICLOVIR INJECTION PROVIDES A PROLONGED THERAPEUTIC INTRAOCULAR CONCENTRATION, British journal of ophthalmology, 80(3), 1996, pp. 214-216
Background-Although intravitreal high dose ganciclovir has previously
been found to provide excellent control of cytomegalovirus (CMV) retin
itis, little was known about the vitreous concentrations of ganciclovi
r after a 2 mg intravitreal injection. Methods-Eleven vitreous samples
were taken from seven patients with CMV retinitis at 24 and 72 hours
after a 2 mg intravitreal injection of ganciclovir and the concentrati
on of ganciclovir was measured by high performance liquid chromatograp
hy. Results-The mean concentration of ganciclovir at 24 hours was 143.
8 mg/l (95% confidence interval 97.8-190) and at 72 hours was 23.4 mg/
l (95% CI 0-49.7). The half life ranged from 11.9 to 26.3 (mean 18.8)
hours in the four patients who had two samples taken. The mean half li
fe calculated from the mean concentrations at 24 and 72 hours was 18.3
hours, so the calculated mean concentration at 7 days was 0.6 mg/l. C
onclusions-This suggests that it takes about 7 days to eliminate the i
ntravitreal ganciclovir, and that it is not Likely to accumulate with
weekly injections. The intravitreal concentrations achieved with high
dose therapy remained above the ID50 for CMV (0.25-1.22 mg/l) for up t
o 7 days.